References
- Fulkerson HL, Nogalski MT, Collins-McMillen D, et al. Overview of human cytomegalovirus pathogenesis. Methods Mol Biol. 2021;2244:1–18.
- Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–213.
- Trombetta CM, et al. Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy). J Prev Med Hyg. 2021;62:E372–E376.
- EpiCentro. Citomegalovirus - Istituto Superiore di Sanità [Internet]. [cited 2021 Nov 15]. Available from: https://www.epicentro.iss.it/citomegalovirus/.
- Nigro G, La Torre R, Sali E, et al. Intraventricular haemorrhage in a fetus with cerebral cytomegalovirus infection. Prenat Diagn. 2002;22(7):558–561.
- Nigro G, Adler SP, Parruti G, et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy-a case-control study of the outcome in children. J Infect Dis. 2012;205(2):215–227.
- Enders M, Daiminger A, Exler S, et al. Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks’ threshold. Prenat Diagn. 2017;37(9):940–942.
- Pass RF, Arav-Boger R. Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. F1000Res. 2018;7:255.
- Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2008;197(2):65–73.
- Leruez-Ville M, Ghout I, Bussières L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016;215(4):462.e1–462.e10.
- Shahar-Nissan K, Pardo J, Peled O, et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet. 2020;396(10253):779–785.
- Bartlett AW, Hamilton ST, Shand AW, et al. Fetal therapies for cytomegalovirus: What we tell prospective parents. Prenat Diagn. 2020;40(13):1681–1692.
- CMV screening. Italian Parliament. Bill no. 2265/2021. [cited 2021 Nov 15]. Available from: https://www.senato.it/service/PDF/PDFServer/BGT/01302999.pdf.
- Italian Supreme Court, application no. 653, 15 January 2021. [cited 2021 Nov 15]. Available from: http://www.italgiure.giustizia.it/xway/application/nif/clean/hc.dll?verbo=attach&db=snciv&id=./20210115/snciv@s30@a2021@[email protected].
- Frati P, Gulino M, Turillazzi E, et al. The physician’s breach of the duty to inform the parent of deformities and abnormalities in the foetus: “Wrongful Life” actions, a new frontier of medical responsibility. J Matern Fetal Neonatal Med. 2014;27(11):1113–1117. Jul
- Chindemi D. Responsabilità del medico e della struttura sanitaria pubblica e privata. Vicenza: Altalex, 2018. p. 296–338.
- Scurria S, Asmundo A, Gualniera P. Cross-country comparative analysis of legislation and court rulings in wrongful birth actions. J Leg Med. 2019;39(1):35–53.
- World Health Organization WHO. Safe abortion: technical and policy guidance for health systems, 2012. [cited 2021 Nov 15]. Available from: http://www.who.int/reproductivehealth/publications/unsafe_abortion/9789241548434/en/.
- Erdman JN. Theorizing time in abortion law and human rights. Health Hum Rights. 2017;19:29–40.
- Gissler M, Fronteira I, Jahn A, et al. Terminations of pregnancy in the European Union. BJOG. 2012;119(3):324–332.
- The World’s Abortion Laws | Center for Reproductive Rights [Internet]. [cited 2021 Dec 13]. Available from: https://maps.reproductiverights.org/worldabortionlaws.
- Zaręba K, Herman K, Kołb-Sielecka E, et al. Abortion in countries with restrictive abortion laws—possible directions and solutions from the perspective of Poland. Healthcare (Basel). 2021;9(11):1594.
- Benoist G, Leruez-Ville M, Magny JF, et al. Management of pregnancies with confirmed cytomegalovirus fetal infection. Fetal Diagn Ther. 2013;33(4):203–214.
- Hermerén G. The principle of proportionality revisited: interpretations and applications. Med Health Care Philos. 2012;15(4):373–382.
- Tambone V, Sacchini D. Prevention of the maternal-fetal CMC infection: ethical and deontologic aspects. Clin Ter. 2004;155(10):471–475.
- Carlson A, Norwitz ER, Stiller RJ. Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obstet Gynecol. 2010;3(4):172–179.
- Lipitz S, Yinon Y, Malinger G, et al. Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet Gynecol. 2013;41(5):508–514.
- Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect. 2011;17(9):1285–1293.
- Gievers LL, Holmes AV, Loyal J, et al. Ethical and public health implications of targeted screening for congenital cytomegalovirus. Pediatrics. 2020;146(1):e20200617.
- Italian Guidelines for physiological pregnancy. Minister of health. 2011. [cited 2021 Nov 15]. Available from: https://www.salute.gov.it/imgs/C_17_pubblicazioni_1436_allegato.pdf.
- Pass RF, Hutto C, Ricks R, et al. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med. 1986;314(22):1414–1418.
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–363.
- Verghini E, Di Pietro ML, Virdis A, et al. Congenital rubella syndrome: seeking damages to be born. Ethical, medical and public health considerations. J Matern Fetal Neonatal Med. 2011;24(12):1417–1420.
- Constitution of the World Health Organization 2006. [cited 2021 Nov 15]. Available from: https://www.who.int/governance/eb/who_constitution_en.pdf.
- Scott R. Risks, reasons and rights: the European convention on human rights and English abortion law. Med Law Rev. 2016;24(1):1–33.